Neuphoria Therapeutics (NEUP) Q4 2024 Earnings

14NovConfirmed
Q4 2024
-2.01
-1.68
-1.34
-1.01

Details

Expected EPS
N/A
Actual EPS
-2.01
Surprise EPS
-2.01
Surprise Percent
+∞%

Description

Neuphoria Therapeutics (NEUP) has reported earnings of -2.01 per share for Q4 2024.

0 Comments

Share your thoughts